s6y
Company name or ticker
Search
Hamel Lawrence G
4
ACELRX PHARMACEUTICALS INC: Statement of changes in beneficial ownership of securities
Filed
Monday, November 4, 2019
Period
Nov 2, 2019
Accession number
0000899243-19-026513
Documents
FORM 4 SUBMISSION
4
EX-24.1 DOCUMENT
EX-24.1
On sec.gov
Filing index
All files
Complete submission text
SGML header